K.K. Serusido
Romanized株式会社 セルシード
About this English name
Auto-romanized from the registered Japanese kana reading. Not an officially registered English name.
For sanctions screening or contractual purposes, always cross-reference using the Corporate Number (法人番号) shown above, not the English name.
Enforcement records (3)
- Oct 5, 2017先駆け審査指定制度対象品目の募集薬事法Ministry of Health, Labour and Welfare
Suppression of stenosis and reduction of days until re-epithelialization after endoscopic submucosal dissection (ESD) for esophageal cancer using oral mucosa-derived esophageal cell sheet
- Feb 28, 2017指定Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and Welfare
患者自身の口腔粘膜から採取した上皮細胞を培養した細胞シートであり、食道がんにおける広範囲内視鏡的粘膜下層剥離術（ESD）後の狭窄の抑制及び再上皮化までの日数の短縮目的とするものである。
- Feb 28, 2017指定薬事法Ministry of Health, Labour and Welfare
The product is a cell sheet cultured from the patient's own oral mucosal epithelial cells, intended to prevent stenosis and shorten the time to re-epithelialization after endoscopic submucosal dissection (ESD) for esophageal cancer. Two clinical studies in Japan (19 cases) have been conducted, showing promising results with a high non-stenosis rate of 64%.
Watch this company
Get an email when K.K. Serusido has new enforcement actions or registry changes. Sign-in is via a one-time email link — no password required.
Language
日本語版を見る (Japanese)Registry data
- Status
- Active
For compliance use
This profile aggregates public Japanese government records. Always cross-reference the Corporate Number when matching this entity in your systems — Japanese English company names are often inconsistent across sources.